Patents by Inventor Matthew Kirkham

Matthew Kirkham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
    Patent number: 7368248
    Abstract: The present invention relates to the significant functional role of several C. elegans genes and of their corresponding gene products in cell division and proliferation processes that could be identified by means of RNA-medicated interference (RNAi) and to the identification and isolation of functional orthologues of said genes including all biologically-active derivatives thereof. The invention further relates to the use of said gene products (including said orthologues) in the development or isolation of anti-proliferative agents, particularly their use in appropriate screening assays, and their use for diagnosis and treatment of proliferative diseases.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: May 6, 2008
    Assignee: Cenix Bioscience GmbH
    Inventors: Christophe Echeverri, Pierre Goenczy, Anthony Hyman, Steven Jones, Karen Oegema, Matthew Kirkham
  • Electroluminescent boron complexes
    Publication number: 20070042219
    Abstract: Novel boron complexes are blue emissive electroluminescent compounds.
    Type: Application
    Filed: March 12, 2004
    Publication date: February 22, 2007
    Inventors: Poopathy Kathirgamanathan, Matthew Kirkham, Alexander Lay, Subramaniam Ganeshamurugan, Gnanamoly Paramaswara, Muttulingam Kumaraverl, Arumugam Parthespan, Selvadurai Selvaranjan, Juan Antipan-Lara, Richard Price, Sivagnanasumdram Surendrakumar
  • Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents
    Publication number: 20050101773
    Abstract: The present invention relates to several C. elegans genes and gene products identified by means of RNA-mediated interference (RNAi) as required for the viability, growth or reproduction of nematodes and to functional orthologues of said genes and gene products found in other nematode species, including all biologically-active derivatives thereof. The invention also comprises the use of said genes and gene products in the development of anti-nematode or other pesticidal agents and in methods for diagnosis and treatment of diseases associated with the infection or presence of nematodes.
    Type: Application
    Filed: November 9, 2001
    Publication date: May 12, 2005
    Inventors: Christophe Echeverri, Pierre Goenczy, Anthony Hyman, Steven Jones, Karen Oegema, Matthew Kirkham
  • Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
    Publication number: 20040048277
    Abstract: The present invention relates to the significant functional role of several C. elegans genes and of their corresponding gene products in cell division and proliferation processes that could be identified by means of RNA-medicated interference (RNAi) and to the identification and isolation of functional orthologues of said genes including all biologically-active derivatives thereof. The invention further relates to the use of said gene products (including said orthologues) in the development or isolation of anti-proliferative agents, particularly their use in appropriate screening assays, and their use for diagnosis and treatment of proliferative diseases.
    Type: Application
    Filed: September 8, 2003
    Publication date: March 11, 2004
    Inventors: Christophe Echeverri, Pierre Goenczy, Anthony Hyman, Steven Jones, Karen Oegema, Matthew Kirkham